DCTH DELCATH SYS INC More: the full row for DELCATH SYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,650,389 shares; 2025Q1: 2,900,389 shares; 2025Q2: 3,300,389 shares; 2025Q3: 3,300,389 shares; 2025Q4: 3,300,389 shares; 2026Q1: 3,300,389 shares; 2026Q2: 3,300,389 shares; 2026Q3: 3,300,389 shares 3,300,389 $52.7M 17.04% 0 2026-10-13, 13D/A : No share count stated, 13D/A filed 2026-10-19 Timeline VSTM VERASTEM INC More: the full row for VERASTEM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 900,000 shares; 2025Q1: 2,644,517 shares; 2025Q2: 2,043,563 shares; 2025Q3: 1,929,563 shares; 2025Q4: 1,788,475 shares; 2026Q1: 2,138,475 shares; 2026Q2: 3,986,509 shares; 2026Q3: 4,236,509 shares 4,236,509 $34.1M 11.03% +250,000 Timeline FENC FENNEC PHARMACEUTICALS INC More: the full row for FENNEC PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,259,876 shares; 2025Q1: 1,782,844 shares; 2025Q2: 2,045,644 shares; 2025Q3: 2,076,840 shares; 2025Q4: 2,613,508 shares; 2026Q1: 2,908,201 shares; 2026Q2: 3,188,001 shares; 2026Q3: 3,188,001 shares 3,188,001 $34M 10.98% 0 Timeline XERS XERIS BIOPHARMA HOLDINGS INC More: the full row for XERIS BIOPHARMA HOLDINGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,104,995 shares; 2025Q1: 2,495,986 shares; 2025Q2: 2,155,594 shares; 2025Q3: 1,795,766 shares; 2025Q4: 2,111,700 shares; 2026Q1: 3,231,700 shares; 2026Q2: 2,908,981 shares; 2026Q3: 2,582,647 shares 2,582,647 $24.7M 7.98% -326,334 Timeline HELP CYBIN INC More: the full row for CYBIN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 810,918 shares; 2025Q1: 810,918 shares; 2025Q2: 810,918 shares; 2025Q3: 1,500,000 shares; 2025Q4: 1,657,540 shares; 2026Q1: 1,531,814 shares; 2026Q2: 1,956,814 shares; 2026Q3: 1,387,969 shares 1,387,969 $17.1M 5.52% -568,845 Timeline SVRA SAVARA INC More: the full row for SAVARA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,654,944 shares; 2025Q1: 2,654,944 shares; 2025Q2: 2,654,944 shares; 2025Q3: 4,000,000 shares; 2025Q4: 3,403,721 shares; 2026Q1: 3,203,721 shares; 2026Q2: 3,178,121 shares; 2026Q3: 3,178,121 shares 3,178,121 $16.4M 5.3% 0 Timeline REPL REPLIMUNE GROUP INC More: the full row for REPLIMUNE GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 260,000 shares; 2025Q1: 850,000 shares; 2025Q2: 900,000 shares; 2025Q3: not reported; 2025Q4: 1,410,497 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,000,000 shares 1,000,000 $13.2M 4.28% new Timeline VOR VOR BIOPHARMA INC More: the full row for VOR BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 700,000 shares; 2026Q2: 648,600 shares; 2026Q3: 609,199 shares 609,199 $11.6M 3.76% -39,401 Timeline MDWD MEDIWOUND LTD More: the full row for MEDIWOUND LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 628,050 shares; 2025Q1: 506,893 shares; 2025Q2: 407,061 shares; 2025Q3: 749,054 shares; 2025Q4: 749,054 shares; 2026Q1: 749,054 shares; 2026Q2: 749,054 shares; 2026Q3: 749,054 shares 749,054 $10.3M 3.34% 0 Timeline XFOR X4 PHARMACEUTICALS INC More: the full row for X4 PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,544,607 shares; 2025Q4: 2,605,920 shares; 2026Q1: 3,214,766 shares; 2026Q2: 3,214,766 shares; 2026Q3: 3,214,766 shares 3,214,766 $9.32M 3.01% 0 Timeline AQST AQUESTIVE THERAPEUTICS INC More: the full row for AQUESTIVE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 2,000,000 shares 2,000,000 $9.26M 2.99% +1,750,000 Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 290,000 shares; 2026Q2: 200,000 shares; 2026Q3: 149,361 shares 149,361 $8.5M 2.75% -50,639 Timeline TARA PROTARA THERAPEUTICS INC More: the full row for PROTARA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,400,000 shares 2,400,000 $7.32M 2.37% new Timeline MYO MYOMO INC More: the full row for MYOMO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,998,945 shares; 2025Q1: 2,703,661 shares; 2025Q2: 3,595,788 shares; 2025Q3: 3,790,788 shares; 2025Q4: 3,839,772 shares; 2026Q1: 3,847,272 shares; 2026Q2: 3,637,886 shares; 2026Q3: 3,917,886 shares 3,917,886 $6.11M 1.98% +280,000 Timeline BCRX BIOCRYST PHARMACEUTICALS INC More: the full row for BIOCRYST PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 923,057 shares; 2026Q2: 721,504 shares; 2026Q3: 721,504 shares 721,504 $6.01M 1.94% 0 Timeline RCKT ROCKET PHARMACEUTICALS INC More: the full row for ROCKET PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,200,000 shares 2,200,000 $5.79M 1.87% new Timeline PEPG PEPGEN INC More: the full row for PEPGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 350,000 shares; 2026Q3: 2,000,000 shares 2,000,000 $4.84M 1.57% +1,650,000 Timeline PROF PROFOUND MED CORP More: the full row for PROFOUND MED CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 692,185 shares; 2025Q1: 692,185 shares; 2025Q2: 692,185 shares; 2025Q3: 692,185 shares; 2025Q4: 1,068,955 shares; 2026Q1: 828,118 shares; 2026Q2: 828,118 shares; 2026Q3: 828,118 shares 828,118 $4.8M 1.55% 0 Timeline TLPH TALPHERA INC More: the full row for TALPHERA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 613,939 shares; 2025Q1: 2,003,939 shares; 2025Q2: 2,003,939 shares; 2025Q3: 4,385,757 shares; 2025Q4: 3,579,273 shares; 2026Q1: 3,353,916 shares; 2026Q2: 5,169,501 shares; 2026Q3: 4,134,144 shares 4,134,144 $4.8M 1.55% -1,035,357 Timeline NRXS NEURAXIS INC More: the full row for NEURAXIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 286,138 shares; 2026Q1: 286,138 shares; 2026Q2: 508,055 shares; 2026Q3: 548,123 shares 548,123 $4.04M 1.31% +40,068 Timeline OVID OVID THERAPEUTICS INC More: the full row for OVID THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 500,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,107,994 shares; 2026Q2: 1,107,994 shares; 2026Q3: 1,107,994 shares 1,107,994 $2.76M 0.89% 0 Timeline NSPR INSPIREMD INC More: the full row for INSPIREMD INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,495,783 shares; 2025Q1: 2,274,990 shares; 2025Q2: 2,289,099 shares; 2025Q3: 3,905,743 shares; 2025Q4: 3,905,743 shares; 2026Q1: 3,905,743 shares; 2026Q2: 3,905,743 shares; 2026Q3: 3,905,743 shares 3,905,743 $2.62M 0.85% 0 Timeline ABOS ACUMEN PHARMACEUTICALS INC More: the full row for ACUMEN PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,100,000 shares 1,100,000 $2.44M 0.79% new Timeline EYPT EYEPOINT INC More: the full row for EYEPOINT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 650,000 shares; 2025Q4: 690,000 shares; 2026Q1: 1,036,737 shares; 2026Q2: 988,230 shares; 2026Q3: 695,977 shares 695,977 $2.28M 0.74% -292,253 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,869 shares; 2026Q3: 20,869 shares 20,869 $2.07M 0.67% 0 Timeline BFRI BIOFRONTERA INC More: the full row for BIOFRONTERA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 811,918 shares; 2025Q1: 644,393 shares; 2025Q2: 976,448 shares; 2025Q3: 1,140,764 shares; 2025Q4: 1,140,764 shares; 2026Q1: 1,163,962 shares; 2026Q2: 1,275,609 shares; 2026Q3: 1,789,288 shares 1,789,288 $1.93M 0.62% +513,679 Timeline FEMY FEMASYS INC More: the full row for FEMASYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 759,213 shares 759,213 $1.64M 0.53% new Timeline AVIR ATEA PHARMACEUTICALS INC More: the full row for ATEA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,171,855 shares; 2026Q2: 1,070,550 shares; 2026Q3: 280,061 shares 280,061 $1.46M 0.47% -790,489 Timeline CGON CG ONCOLOGY INC More: the full row for CG ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 192,974 shares; 2025Q3: 300,000 shares; 2025Q4: 300,000 shares; 2026Q1: 100,000 shares; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000 $1.42M 0.46% new Timeline SPRB SPRUCE BIOSCIENCES INC More: the full row for SPRUCE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,000 shares; 2026Q3: 26,517 shares 26,517 $1.29M 0.42% +6,517 Timeline RGNT REGENTIS BIOMATERIALS LTD More: the full row for REGENTIS BIOMATERIALS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 251,510 shares; 2026Q1: 251,510 shares; 2026Q2: 701,685 shares; 2026Q3: 701,685 shares 701,685 $1.27M 0.41% 0 Timeline KURA KURA ONCOLOGY INC More: the full row for KURA ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 100,000 shares; 2025Q2: 100,000 shares; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000 $1.07M 0.35% 0 Timeline GRCE GRACE THERAPEUTICS INC More: the full row for GRACE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 476,190 shares 476,190 $1.02M 0.33% new Timeline PYPD POLYPID LTD More: the full row for POLYPID LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,018,021 shares; 2025Q1: 1,018,021 shares; 2025Q2: 975,462 shares; 2025Q3: 918,668 shares; 2025Q4: 696,556 shares; 2026Q1: 597,926 shares; 2026Q2: 389,455 shares; 2026Q3: 177,011 shares 177,011 $933K 0.3% -212,444 Timeline OKUR ONKURE THERAPEUTICS INC More: the full row for ONKURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 730,488 shares; 2026Q1: 443,763 shares; 2026Q2: 150,000 shares; 2026Q3: 67,506 shares 67,506 $184K 0.06% -82,494 Timeline